← Leaderboards
Cecilia J Hillard
Medical College Of Wisconsin
$13,181,596
Attributed
$20,952,726
Total exposure
21
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,952,726 · 21
By mechanism
R01$17,926,012 · 11
R21$2,476,230 · 6
R56$376,484 · 1
R03$154,000 · 1
R13$20,000 · 2
Top collaborators
- John R Mantsch11 shared
- William R. Drobyski8 shared
- Qing-Song Liu5 shared
- Terri A. Deroon-Cassini3 shared
- Krista Lisdahl Medina3 shared
- Christopher W Cunningham2 shared
- Joseph S Goveas2 shared
- Elizabeth S Liedhegner2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- David R Harder$18,930,514
- Shi-Jiang Li$13,473,897
- Allen W Cowley$26,782,337
- Albert W Girotti$6,660,539
- Qing-Song Liu$9,331,514
Others in their field
Top investigators on “Endocannabinoids”
- Alexandros Makriyannis · University Of Connecticut Storrs$17,718,797
- Daniele Piomelli · University Of California Irvine$17,073,937
- Sachin Patel · Medical College Of Wisconsin$14,177,490
- Joseph F Cheer · University Of Maryland Baltimore$12,625,135
- Benjamin F Cravatt · Scripps Research Institute$12,090,393
- Nephi Stella · University Of Washington$11,759,645
Research focus
Endocannabinoids2-ArachidonylglycerolSignal TransductionBrainMediatingPlayRegulationStressAffectResponseSiteCnr1 GeneReceptorPathway InteractionsLigandsCannabinoid ReceptorBehaviorBehavioralCannabinoidsNeuronsEndocannabinoid SignalingSourceAnxietyLead
Grant awards (61)
Development of sterol carrier protein 2 inhibitors as anxiolytics$651,412
R01 · FY2025 · MH · contact PI
Examining the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the ABCD Study$621,186
R01 · FY2025 · DA
Mechanisms underlying the influence of stress on drug-seeking behavior$588,293
R01 · FY2025 · DA
2025 Cannabinoid Function in the CNS Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2025 · DA · contact PI
Development of sterol carrier protein 2 inhibitors as anxiolytics$679,286
R01 · FY2024 · MH · contact PI
Mechanisms underlying the influence of stress on drug-seeking behavior$590,386
R01 · FY2024 · DA
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$700,162
R01 · FY2023 · HL
Mechanisms underlying the influence of stress on drug-seeking behavior$586,247
R01 · FY2023 · DA
Circuit-specific actions of endocannabinoids in stress and mood disorders$385,000
R01 · FY2023 · MH
2023 Cannabinoid Function in the CNS Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2023 · DA · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$700,162
R01 · FY2022 · HL
Circuit-specific actions of endocannabinoids in stress and mood disorders$385,000
R01 · FY2022 · MH
Studies of Cannabidiol in Neurodevelopment$195,000
R21 · FY2022 · DA · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$700,162
R01 · FY2021 · HL
Circuit-specific actions of endocannabinoids in stress and mood disorders$385,000
R01 · FY2021 · MH
Studies of Cannabidiol in Neurodevelopment$234,000
R21 · FY2021 · DA · contact PI
Mechanistic Inflammatory Pathways in Graft Versus Host Disease$695,482
R01 · FY2020 · HL
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$543,312
R01 · FY2020 · HL
Circuit-specific actions of endocannabinoids in stress and mood disorders$385,000
R01 · FY2020 · MH
Examining the impact of circulating endocannabinoid levels on neurocognition, mood, and early cannabis use in youth enrolled in the ABCD Study$152,660
R21 · FY2020 · DA
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$543,312
R01 · FY2019 · HL
Circuit-specific actions of endocannabinoids in stress and mood disorders$385,000
R01 · FY2019 · MH
Acute Endocannabinoid activity involved in hyperarousal, memory formation, and non-remitting PTSD: A dense sampling approach$376,484
R56 · FY2019 · MH
Examining the impact of circulating endocannabinoid levels on neurocognition, mood, and early cannabis use in youth enrolled in the ABCD Study$280,160
R21 · FY2019 · DA
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$538,692
R01 · FY2018 · HL
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$532,423
R01 · FY2018 · DA
Endocannabinoid System and Brain Network Function in Late-Life Depression$192,500
R21 · FY2018 · MH
Cannabinoid-mediated mitigation of graft versus host disease: Roles of CB2 receptors and adenosine signaling$538,692
R01 · FY2017 · HL
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$532,143
R01 · FY2017 · DA
Endocannabinoid System and Brain Network Function in Late-Life Depression$231,000
R21 · FY2017 · MH
CB2 Cannabinoid Receptors and Cocaine Action: Studies with Conditional Knock Outs$192,500
R21 · FY2017 · DA · contact PI
Sex differences in stress-potentiated cocaine seeking and the underlying mechanisms$98,150
R01 · FY2017 · DA
Circulating endocannabinoids in rats: Assay development and validation$77,000
R03 · FY2017 · DA · contact PI
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$433,574
R01 · FY2016 · DA
CB2 Cannabinoid Receptors and Cocaine Action: Studies with Conditional Knock Outs$230,625
R21 · FY2016 · DA · contact PI
Circulating endocannabinoids in rats: Assay development and validation$77,000
R03 · FY2016 · DA · contact PI
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$7,193
R01 · FY2016 · DA
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$436,754
R01 · FY2015 · DA
Role of ECS in Resilience & Psychopathology After Trauma$189,000
R21 · FY2015 · MH
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$6,640
R01 · FY2015 · DA
Glucocorticoid-regulated endocannabinoids and stress-potentiated cocaine seeking$447,603
R01 · FY2014 · DA
Cannabinoid regulation of glycogen synthase kinase-3$350,170
R01 · FY2014 · DA · contact PI
Role of ECS in Resilience & Psychopathology After Trauma$157,500
R21 · FY2014 · MH
Cannabinoid regulation of glycogen synthase kinase-3$336,163
R01 · FY2013 · DA · contact PI
Cannabinoid regulation of glycogen synthase kinase-3$350,170
R01 · FY2012 · DA · contact PI
Cannabinoid regulation of glycogen synthase kinase-3$350,170
R01 · FY2011 · DA · contact PI
Biochemistry of Anandamide, An Endogenous Cannabinoid$320,795
R01 · FY2011 · DA · contact PI
Biochemistry of Anandamide, An Endogenous Cannabinoid$330,717
R01 · FY2010 · DA · contact PI
Cannabinoid regulation of glycogen synthase kinase-3$304,000
R01 · FY2010 · DA · contact PI
Biochemistry of Anandamide, An Endogenous Cannabinoid$334,058
R01 · FY2009 · DA · contact PI
Biochemistry of Anandamide, An Endogenous Cannabinoid$167,200
R01 · FY2009 · DA · contact PI
Gender differences in the interactions between endocannabinoids and stress$223,370
R21 · FY2008 · DA · contact PI
Gender differences in the interactions between endocannabinoids and stress$197,915
R21 · FY2007 · DA · contact PI
Cannabinoid Receptors and Cerebrovascular Function$278,303
R01 · FY2006 · NS · contact PI
Brain Endocannabinoids and Chronic Stress$300,000
R01 · FY2005 · DA
Cannabinoid Receptors and Cerebrovascular Function$285,000
R01 · FY2005 · NS
Cannabinoid Receptors and Cerebrovascular Function$285,000
R01 · FY2004 · NS
Brain Endocannabinoids and Chronic Stress$262,500
R01 · FY2004 · DA
Brain Endocannabinoids and Chronic Stress$37,500
R01 · FY2004 · DA
Cannabinoid Receptors and Cerebrovascular Function$275,500
R01 · FY2003 · NS
Brain Endocannabinoids and Chronic Stress$262,500
R01 · FY2003 · DA